Statins - The HMG CoA reductase inhibitors in perspective (Hardcover, 2nd edition)

Contents:
1. Hyperlipidaemia as a Risk Factor for Coronary Heart Disease 2. Lipid Control in the Pre-Statin Era 3. The Discovery and Development of the Statins 4. Comparative Chemistry, Pharmacology and the Mechanism of Action of the Statins 5. Ancillary Benefits of the Statins 6. Angiographic and IVUS Techniques Evaluating Progression and Regression of Coronary Atherosclerosis: Statin Intervention Trials in Perspective 7. The Scandanavian Simvastatin Survival Study (4S) 8. Primary Prevention of Coronary Heart Disease with Statins 9. The CARE (Cholesterol and Recurrent Events) Trial: The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels 10. The LIPID (Long-term Intervention with Pravastatin in Ischemic Disease) Study: Results and Implications for Clinical Practice 11. Mega-trials: the Prospective Pravastatin Pooling Project (PPP) and the Heart Protection Study (HPS) 12. The Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) 13. Combination Therapy with Statins 14. Guidelines for Clinical Use of the Statins 15. The Cost-effectiveness of Statin Use 16. Unanswered Questions About the Use of Statins 17. Statin Therapy for the 21st Century

General

Imprint:	Crc Press
Country of origin:	United Kingdom
Release date:	December 2003
First published:	2003
Editors:	Allan Gaw • Christopher Packard • James Shepherd
Dimensions:	234 x 156 x 19mm (L x W x T)
Format:	Hardcover
Pages:	272
Edition:	2nd edition
ISBN-13:	978-1-84184-292-9
Categories:	Books > Medicine > Other branches of medicine > Pharmacology > General Promotions
LSN:	1-84184-292-3
Barcode:	9781841842929

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!